Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BMS-986226 |
Trade Name | |
Synonyms | BMS986226|BMS 986226 |
Drug Descriptions |
BMS-986226 is a monoclonal antibody that targets ICOS (inducible T-cell costimulator, CD278) to activate T-cells in the immune anti-tumor response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C146762 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BMS-986226 | BMS-986226 | 0 | 1 |
BMS-986226 + Ipilimumab | BMS-986226 Ipilimumab | 0 | 1 |
BMS-986226 + Nivolumab | BMS-986226 Nivolumab | 0 | 1 |